Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We present a case of invasive pneumococcal disease (IPD) complicated by both iliopsoas abscess and pyogenic vertebral osteomyelitis caused by serotype 35F in a 64-year-old man with a history of splenectomy who was unvaccinated. The patient experienced difficulty moving, severe back pain, vomiting, and high fever. Advanced imaging techniques, including T2-weighted lumbar MRI and diffusion-weighted whole-body imaging with background body signal suppression (DWIBS), revealed hyperintensities in the left iliopsoas muscle and L4-L5 vertebral bodies, facilitating diagnosis. Blood cultures confirmed the presence of serotype 35F , a non-vaccine type associated with an increased risk of invasive disease and mortality. The patient was successfully treated with targeted antibiotics and disc lavage, resulting in symptom resolution. To our knowledge, this is the first reported case of serotype 35F causing both iliopsoas abscess and vertebral osteomyelitis, making it a noteworthy contribution to medical literature. Notably, DWIBS proved to be a valuable adjunct diagnostic tool, highlighting its potential for visually accessible, comprehensive screening of inflammation and abscesses throughout the body. We believe that DWIBS is particularly useful when bacteria capable of inducing lesions in multiple organs, such as or are isolated from blood cultures. Although DWIBS is still emerging in infectious disease diagnostics, this case underscores its promising role in detecting abscesses and inflammatory lesions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12337593PMC
http://dx.doi.org/10.7759/cureus.87770DOI Listing

Publication Analysis

Top Keywords

serotype 35f
16
vertebral osteomyelitis
12
iliopsoas abscess
12
pyogenic vertebral
8
invasive pneumococcal
8
pneumococcal disease
8
diffusion-weighted whole-body
8
whole-body imaging
8
imaging background
8
background body
8

Similar Publications

Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007-23).

J Antimicrob Chemother

August 2025

Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada R3E 0J9.

Objectives: To compare the antimicrobial resistance and serotype patterns in Streptococcus pneumoniae collected from blood cultures and respiratory specimens in Canada from 2007 to 2023.

Methods: S. pneumoniae isolates were submitted from Canadian hospitals as part of the ongoing national surveillance study, CANWARD.

View Article and Find Full Text PDF

We present a case of invasive pneumococcal disease (IPD) complicated by both iliopsoas abscess and pyogenic vertebral osteomyelitis caused by serotype 35F in a 64-year-old man with a history of splenectomy who was unvaccinated. The patient experienced difficulty moving, severe back pain, vomiting, and high fever. Advanced imaging techniques, including T2-weighted lumbar MRI and diffusion-weighted whole-body imaging with background body signal suppression (DWIBS), revealed hyperintensities in the left iliopsoas muscle and L4-L5 vertebral bodies, facilitating diagnosis.

View Article and Find Full Text PDF

Nasopharyngeal carriage of Streptococcus pneumoniae in children plays a key role in transmission and disease epidemiology, hence it is crucial to monitor colonisation. As PCV-15 has recently replaced PCV-13 in Hungary, the aim of the study was to survey colonisation epidemiology 12-13 years post-PCV-13. 401 children, attending day care centres at Northern Hungary (including Budapest) were screened between April 2022 and April 2023.

View Article and Find Full Text PDF

A comprehensive analysis of serotype-specific invasive capacity, clinical presentations, and mortality trends of invasive pneumococcal disease.

Vaccine

February 2025

Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale University School of Medicine, New Haven, CT, United States; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States; Yale Institute for Global Health, Yale Universit

Background: Pneumococcal conjugate vaccines (PCV) reduced invasive disease, but the overall prevalence of pneumococcal nasopharyngeal colonization among children has not changed significantly. Our knowledge of which serotypes, once colonized, hold a higher likelihood to cause invasive disease is limited.

Methods: Serotype-specific invasive capacity (IC) of Streptococcus pneumoniae was estimated using an enhanced population-based invasive pneumococcal disease (IPD) surveillance in children <7 years of age in Massachusetts and surveillance of nasopharyngeal (NP) colonization in selected Massachusetts communities in corresponding respiratory seasons.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the carriage rate, serotype distribution, and antibiotic susceptibility of a specific bacteria in patients with acute respiratory infections in Manado, North Sulawesi, before the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13).
  • A total of 106 nasopharyngeal swabs were collected, revealing a higher carriage rate among children aged 2-5 years (40.6%) compared to younger kids and adults.
  • The identified serotypes varied, including several strains, and most isolates showed high susceptibility to antibiotics like vancomycin and chloramphenicol, while resistance was noted for penicillin and sulfamethoxazole/trimethoprim, providing baseline data for future
View Article and Find Full Text PDF